Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Select appropriate initial therapy using clinical evidence, guidelines, and patient- and disease-specific factors (including biomarkers)
- Develop longitudinal treatment strategies that incorporate sequencing across lines of therapy, prior treatment exposure, and anticipated next-line options
Saad Z. Usmani, MD, MBA, FACP, FASCO
Professor
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY
Noffar Bar, MD
Assistant Professor of Medicine
Yale School of Medicine
New Haven, CT
Charalampos Charalampous, MD
PGY-4 Hematology-Oncology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY
Patrick Gould, MD
Hematology and Oncology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY
Thomas Martin, MD
Clinical Professor of Medicine
Adult Leukemia and Bone Marrow
Transplantation Program
Associate Director, Myeloma Program, UCSF
Co-Leader, Cancer Immunology &
Immunotherapy Program
Helen Diller Family Comprehensive Cancer
Center
University of California, San Francisco
San Francisco, CA
Andrew Yee, MD
Clinical Director, Center for Multiple
Myeloma
Assistant Professor of Medicine, Harvard
Medical School
Massachusetts General Hospital
Boston, MA
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
